Exenatide promotes weight loss when added to diet and exercise

Jun 11, 2009

In combination with diet and exercise, the diabetes drug exenatide helped nondiabetic, obese individuals lose over three times more weight than those receiving a placebo, or dummy treatment, for 6 months.

Previous studies show that exenatide, an injectable medication marketed as Byetta (Amylin Pharmaceuticals and Eli Lilly and Company), not only lowers blood sugar but also can result in in some people with diabetes. This study, financed by both pharmaceutical companies, is "the first to assess the effect of exenatide on body weight in nondiabetic obese individuals," said the principal investigator, Michael Trautmann, MD, a researcher with Eli Lilly in Indianapolis.

"Drug therapy is considered important adjunctive treatment to diet and exercise in the successful management of obesity," Trautmann said. "To date, however, there are few effective drugs that help obese people lose weight."

Trautmann and colleagues studied 152 patients in the United States—27 men and 125 women—who were obese (, or BMI, greater than 30). The study subjects had an average weight of about 241 pounds (108.6 kilograms) and an average BMI of 39.6. Of the 152 subjects, 38 (25%) had impaired glucose tolerance. None of the subjects took another weight loss medication during the study or in the several months preceding the study.

Subjects were randomly assigned to receive an injection of either exenatide, 10 micrograms twice a day (73 subjects), or placebo (79 subjects), along with a structured lifestyle modification program involving diet and exercise, for 24 weeks. Neither the subjects nor the staff giving the treatments knew which individuals received the study medication. There was no statistically significant difference in beginning weight between the exenatide-treated subjects and the control subjects, who got the placebo injection.

Individuals who received exenatide lost more weight in 24 weeks than controls did, the authors reported. Those who received the medication lost an average of more than 11 pounds (5.06 kg), whereas the controls lost just 3.5 pounds (1.61 kg). This difference was statistically significant and noted as early as week 8. Only exenatide-treated subjects lost more than 10 percent of their body weight (seven of 73 subjects, or 9.6%).

The most common side effects of exenatide were mild or moderate nausea and diarrhea, but weight loss was independent of nausea, the authors reported. Although exenatide lowers blood glucose, or sugar, levels in people with diabetes, it is known to only act in the presence of high blood glucose so that no subjects reported low blood sugar.

Possible reasons why exenatide may cause weight loss include decreased food intake and increased feelings of fullness, he explained.

Source: The Endocrine Society (news : web)

Explore further: Keep your teens safe on the road this summer

add to favorites email to friend print save as pdf

Related Stories

Portion-control dishes may help obese diabetics lose weight

Jun 25, 2007

A plate and cereal bowl with markers for proper portion sizes appear to help obese patients with diabetes lose weight and decrease their use of glucose-controlling medications, according to a report in the June 25 issue of ...

Weight loss reduces incontinence for women

Jan 28, 2009

Starting a weight-loss regimen significantly reduces urinary incontinence for women, according to researchers at the University of Alabama at Birmingham (UAB) and the University of California, San Francisco.

Fatty liver disease medication may have no effect

Jan 13, 2009

A new randomized, prospective trial has shown that orlistat, a commonly prescribed inhibitor of fat absorption, does not help patients with fatty liver disease (FLD) lose weight, nor does it improve their liver enzymes or ...

Recommended for you

Keep your teens safe on the road this summer

2 hours ago

(HealthDay)—Car crashes are the leading cause of accidental death among American teens, and parents need to take steps to keep their teens safe when they're on the road this summer, an expert says.

Survey finds sharp increase in teen use of HGH

3 hours ago

(AP)—Experimentation with human growth hormones by America's teens more than doubled in the past year, as more young people looked to drugs to boost their athletic performance and improve their looks, according ...

Government drafting birth control accommodation

3 hours ago

(AP)—The Obama administration is developing a new way for religious nonprofits that object to paying for contraceptives in their health plans to opt out, without submitting a form they say violates their religious beliefs.

User comments : 0